Spots Global Cancer Trial Database for Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA
Official Title: Comparison of the Diagnostic Yield Between Various Endobronchial Ultrasound-guided-transbronchial Needles (EBUS-TBN) to Evaluate Suspect Mediastinal and Hilar Lymph Nodes
Study ID: NCT02813603
Conditions
Interventions
Study Description
Brief Summary: Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA concerning the diagnostic yield, the quality and quantity of each biopsy needle without raising the rate of complications.
Detailed Description: Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA performed in rigid bronchoscopy for patients with probable lung cancer diagnosis and enlarged mediastinal lymph nodes.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ruhrlandklinik, University Hospital Essen, Essen, NRW, Germany
University Hospital Zürich, Zürich, , Switzerland
Contact Details
Name: Kaid Darwiche, PD Dr. med.
Affiliation: supervising doctor
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
